These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 21374974

  • 1. [Preliminary application of strontium-89 for the treatment of bone metastases from prostate cancer].
    Zhao W, Deng H, Jie P, Qing C, Zhang X.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1251-4. PubMed ID: 21374974
    [Abstract] [Full Text] [Related]

  • 2. [Strontium-89: a desirable therapeutic for bone metastases of prostate cancer].
    Ma YB, Yan WL, Dai JC, Xu F, Yuan Q, Shi HH.
    Zhonghua Nan Ke Xue; 2008 Sep; 14(9):819-22. PubMed ID: 18998467
    [Abstract] [Full Text] [Related]

  • 3. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N.
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bone pain palliation with 85Sr therapy.
    Giammarile F, Mognetti T, Blondet C, Desuzinges C, Chauvot P.
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG, Preston DF, Schiefelbein M, Baxter KG.
    JAMA; 1995 Aug 02; 274(5):420-4. PubMed ID: 7542352
    [Abstract] [Full Text] [Related]

  • 8. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
    Sciuto R, Festa A, Rea S, Pasqualoni R, Bergomi S, Petrilli G, Maini CL.
    J Nucl Med; 2002 Jan 02; 43(1):79-86. PubMed ID: 11801708
    [Abstract] [Full Text] [Related]

  • 9. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
    Papatheofanis FJ.
    J Nucl Med; 1997 Aug 02; 38(8):1175-9. PubMed ID: 9255144
    [Abstract] [Full Text] [Related]

  • 10. Clinical experience with strontium-89 in prostatic and breast cancer patients.
    Robinson RG, Preston DF, Baxter KG, Dusing RW, Spicer JA.
    Semin Oncol; 1993 Jun 02; 20(3 Suppl 2):44-8. PubMed ID: 8503027
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases.
    Storto G, Klain M, Paone G, Liuzzi R, Molino L, Marinelli A, Soricelli A, Pace L, Salvatore M.
    Bone; 2006 Jul 02; 39(1):35-41. PubMed ID: 16434248
    [Abstract] [Full Text] [Related]

  • 13. [Possibilities of systemic radiotherapy with high-purity 89Sr chloride in the treatment of bone metastases].
    Fomin DK, Tararukhina OB, Nazarov AA.
    Vestn Rentgenol Radiol; 2012 Jul 02; (2):29-31. PubMed ID: 22730757
    [Abstract] [Full Text] [Related]

  • 14. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F, Herberg A, Spadaro P, Restifo Pecorella G, Baldari S, Aricò D, Altavilla G, Baldari S.
    Q J Nucl Med Mol Imaging; 2006 Dec 02; 50(4):355-62. PubMed ID: 17043634
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of strontium-89 palliative therapy in patients with painful bone metastases.
    Zorga P, Birkenfeld B, Listewnik MH, Piwowarska-Bilska H.
    Ann Acad Med Stetin; 2011 Dec 02; 57(1):49-53; discussion 53. PubMed ID: 22593991
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
    Ouyang W, Liu JH, Liu WY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar 02; 27(3):390-1. PubMed ID: 17426002
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Decreased serum E-selectin concentration after 89Sr-chloride therapy for metastatic prostate cancer bone pain.
    Papatheofanis FJ.
    J Nucl Med; 2000 Jun 02; 41(6):1021-4. PubMed ID: 10855628
    [Abstract] [Full Text] [Related]

  • 19. [Influence of 89Sr on the cell immune function in patients with multiple bone metastases].
    Wu YG, Ma QL, Liu GF.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Jun 28; 27(3):277-8. PubMed ID: 12575316
    [Abstract] [Full Text] [Related]

  • 20. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
    Pons F, Herranz R, Garcia A, Vidal-Sicart S, Conill C, Grau JJ, Alcover J, Fuster D, Setoain J.
    Eur J Nucl Med; 1997 Oct 28; 24(10):1210-4. PubMed ID: 9323260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.